The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.Consultants, Opioids and Opiates, Drugs (Pharmaceuticals), United States Politics and Government, Pain-Relieving Drugs, OxyContin (Drug), Drug Abuse and Traffic, Food and Drug Administration, McKinsey & Co, Purdue Pharma, Johnson & Johnson, Sternfels, BobRead More
